Safety Alerts Saves Lives
Safety Alerts  
 
Home Privacy About Us Contact Us Change Preferences

SafetyAlerts
March 29, 2002

Novartis Pharmaceuticals Has Recalled Exelon Capsules

Suffern, NY (SafetyAlerts) - The Food and Drug Administration (FDA) said that Novartis Pharmaceuticals Corporation has recalled Exelon Capsules (rivastigmine tartrate), 4.5 mg, 60 capsule bottles.

P
RODUCT
Exelon Capsules (rivastigmine tartrate), 4.5 mg, 60 capsule bottles, Rx Only, labeled as Manufactured by: Novartis Famaceutica, S.A. Barcelona, Spain for Novartis Pharmaceuticals Corporation, East Hanover, New Jersey. Recall # D-215-2.

CODE
Lot 115D1784, expiration date 12/2004 NDC 0078-0325-44.

RECALLING FIRM/MANUFACTURER
Recalling Firm: Novartis Pharmaceuticals Corporation, Suffern, NY, by letter on February 27, 2002.

Manufacturer: Novartis Pharma AG Stein, Switzerland.
Firm initiated recall is ongoing.

REASON
Mis-packaging - (3.0mg capsule in 4.5 mg labeled bottle).

VOLUME OF PRODUCT IN COMMERCE
10,069 bottles.

DISTRIBUTION
Nationwide and Puerto Rico
.

 
Selected Recent Recalls


Health Professional:

Did you know?
During 2000 there were over
1050 products recalled in the United
States for safety reasons!

How many did you hear about?

Sign-up for SafetyAlerts by Email -
The free internet newsletter that could
some day literally save your life - or
the life of someone you know.

   
   

 

The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.